rs121918818

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001165963.4(SCN1A):​c.3101T>C​(p.Ile1034Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,601,554 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00076 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000078 ( 0 hom. )

Consequence

SCN1A
NM_001165963.4 missense

Scores

2
11
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:6

Conservation

PhyloP100: 9.32

Publications

8 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the SCN1A gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 848 curated pathogenic missense variants (we use a threshold of 10). The gene has 89 curated benign missense variants. Gene score misZ: 5.2206 (above the threshold of 3.09). Trascript score misZ: 7.6022 (above the threshold of 3.09). GenCC associations: The gene is linked to familial or sporadic hemiplegic migraine, myoclonic-astatic epilepsy, arthrogryposis, Dravet syndrome, malignant migrating partial seizures of infancy, generalized epilepsy with febrile seizures plus, type 2, migraine, familial hemiplegic, 3, developmental and epileptic encephalopathy, 6A, familial hemiplegic migraine, generalized epilepsy with febrile seizures plus, genetic developmental and epileptic encephalopathy, Lennox-Gastaut syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.02259159).
BP6
Variant 2-166036376-A-G is Benign according to our data. Variant chr2-166036376-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 68613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000762 (116/152292) while in subpopulation AFR AF = 0.00279 (116/41568). AF 95% confidence interval is 0.00238. There are 1 homozygotes in GnomAd4. There are 51 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 116 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1ANM_001165963.4 linkc.3101T>C p.Ile1034Thr missense_variant Exon 19 of 29 ENST00000674923.1 NP_001159435.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1AENST00000674923.1 linkc.3101T>C p.Ile1034Thr missense_variant Exon 19 of 29 NM_001165963.4 ENSP00000501589.1
SCN1AENST00000303395.9 linkc.3101T>C p.Ile1034Thr missense_variant Exon 18 of 28 5 ENSP00000303540.4
SCN1AENST00000375405.7 linkc.3068T>C p.Ile1023Thr missense_variant Exon 16 of 26 5 ENSP00000364554.3
SCN1AENST00000409050.2 linkc.3017T>C p.Ile1006Thr missense_variant Exon 18 of 28 5 ENSP00000386312.1

Frequencies

GnomAD3 genomes
AF:
0.000762
AC:
116
AN:
152174
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00280
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000209
AC:
50
AN:
238888
AF XY:
0.000124
show subpopulations
Gnomad AFR exome
AF:
0.00296
Gnomad AMR exome
AF:
0.0000937
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000780
AC:
113
AN:
1449262
Hom.:
0
Cov.:
35
AF XY:
0.0000639
AC XY:
46
AN XY:
720228
show subpopulations
African (AFR)
AF:
0.00308
AC:
100
AN:
32516
American (AMR)
AF:
0.000166
AC:
7
AN:
42080
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25488
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39596
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52978
Middle Eastern (MID)
AF:
0.000352
AC:
2
AN:
5678
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1107904
Other (OTH)
AF:
0.0000669
AC:
4
AN:
59774
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000762
AC:
116
AN:
152292
Hom.:
1
Cov.:
33
AF XY:
0.000685
AC XY:
51
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00279
AC:
116
AN:
41568
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000452
Hom.:
0
Bravo
AF:
0.000922
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000247
AC:
30

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN1A: BS1 -

Sep 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 12610651) -

Autism Uncertain:1
-
UniProtKB/Swiss-Prot
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Jul 30, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 01, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SCN1A-related disorder Benign:1
Jan 31, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.72
.;.;.;D;.;.;D;.;.;.
Eigen
Benign
0.16
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D;D;D;D;.;D;.;.;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.023
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.044
D
MutationAssessor
Uncertain
2.2
.;.;.;M;.;.;M;.;.;.
PhyloP100
9.3
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-2.8
.;.;.;D;.;.;D;.;D;D
REVEL
Pathogenic
0.67
Sift
Uncertain
0.0030
.;.;.;D;.;.;D;.;D;D
Sift4G
Benign
0.17
.;.;.;T;.;.;T;.;T;T
Polyphen
0.17, 0.062
.;.;.;B;B;.;B;B;B;.
Vest4
0.67, 0.49, 0.51, 0.57
MVP
0.74
MPC
1.2
ClinPred
0.19
T
GERP RS
5.4
Varity_R
0.41
gMVP
0.57
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121918818; hg19: chr2-166892886; API